AstraZeneca PLC is 26.3x more valuable than MADRIGAL PHARMACEUTICALS, INC. by market capitalization ($286.27 B vs $10.87 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | MDGL | AZN |
|---|---|---|
| Market cap | $10.87 B | $286.27 B |
| US-listed rank | #898 | #45 |
| Revenue (latest FY) | $958.40M | - |
| Net income (latest FY) | -$288.28M | - |
| Net margin | -30.1% | - |
| SEC filings | 1,184 | 1,004 |
AstraZeneca PLC is 26.3x more valuable than MADRIGAL PHARMACEUTICALS, INC. by market capitalization ($286.27 B vs $10.87 B).
Full pages: MADRIGAL PHARMACEUTICALS, INC. and AstraZeneca PLC, or browse the full rankings.